In this Healthed, Associate Professor Spiros Fourlanos and Samantha Stuk discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists. Importantly, they will also provide recommendations on how these risks can be mitigated, including the value of nutritional supplements to ensure that the subsequent weight loss is associated with best possible health outcome for the patient.

See omnystudio.com/listener for privacy information.

<p>In this Healthed, Associate Professor Spiros Fourlanos and Samantha Stuk discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists. Importantly, they will also provide recommendations on how these risks can be mitigated, including the value of nutritional supplements to ensure that the subsequent weight loss is associated with best possible health outcome for the patient.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>

Audio versions of Healthed Webcasts, designed for the busy healthcare professional.